Home › Funds › Equitable › EQ/Morgan Stanley Small Cap Growth Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044689
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,555 with, 39 against, 2 abstentions (not counted as with management); 1 items carried no recommendation; 4 split votes are in neither count. Shareholder proposals: 3 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 94.5% | 8,281 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 208 items (2.6% of the 8,100 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 2025-09-10 | To cast a non-binding, advisory vote to approve the compensation of our named executive officers. | For | AGAINST — 8 of 8 Equitable funds | For | Approved, 60.9% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Barbara Bobbie Kilberg | For | WITHHOLD — 7 of 7 Equitable funds | Against | Elected, 96.2% support |
| Appian Corporation | 2026-06-03 | To approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan. | For | AGAINST — 7 of 7 Equitable funds | Against | Approved, 94.2% support |
| Burford Capital Ltd. | 2026-05-13 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement for the 2026 annual general meeting of shareholders under "Executive compensation", including the compensation discussion and analysis, the compensation tables and the rel | For | AGAINST — 7 of 7 Equitable funds | Against | — |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of an amendment and restatement of our amended and restated certificate of incorporation: Approval and adoption of amendments to establish the Class C common stock. | For | AGAINST — 6 of 6 Equitable funds | For | — |
| Cloudflare, Inc. | 2026-06-30 | Approval of one or more adjournments of the meeting, if necessary to solicit additional proxies in favor of the proposals presented at the meeting. | For | AGAINST — 6 of 6 Equitable funds | For | Approved, 66.2% support |
| Cloudflare, Inc. | 2026-06-30 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan. | For | AGAINST — 6 of 6 Equitable funds | For | Approved, 63.1% support |
| Cloudflare, Inc. | 2026-06-30 | Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan. | For | AGAINST — 6 of 6 Equitable funds | For | Approved, 71.6% support |
| Burford Capital Ltd. | 2026-05-13 | To re-elect John Sievwright as director. | For | AGAINST — 6 of 6 Equitable funds | Against | Passed (calculated), 84.8% support |
| Semler Scientific, Inc. | 2025-09-05 | To approve the amendment of Semler Scientific, Inc.'s Restated Certificate of Incorporation, as amended to increase the total number of shares of our common stock authorized for issuance from 50,000,000 shares to 210,000,000 shares. | For | AGAINST — 6 of 6 Equitable funds | Against | Approved, 75.8% support |
| Semler Scientific, Inc. | 2025-09-05 | To approve the amendment of the Restated Certificate of Incorporation, as amended, to authorize the issuance of 42,000,000 shares of "blank-check" preferred stock. | For | AGAINST — 6 of 6 Equitable funds | Against | Not approved, 64.3% support |
| Semler Scientific, Inc. | 2025-09-05 | To elect the following nominee to Class I of our board of directors: William H.C. Chang | For | WITHHOLD — 6 of 6 Equitable funds | Against | Elected, 96.3% support |
| Aurora Innovation, Inc. | 2026-05-21 | Election of Directors: Michelangelo Volpi | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 98.4% support |
| agilon health, inc. | 2026-06-02 | Election of Class II Directors: Ronald Williams | For | AGAINST — 5 of 5 Equitable funds | Against | Elected, 91.4% support |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of amendments to implement a stock split in which (i) each share of Class A common stock would become one share of Class A common stock and one share of Class C common stock; and (ii) each share of Class B common stock would become one share of Class B common stock and one shar | For | AGAINST — 6 of 7 Equitable funds | For | — |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of amendments to increase the number of authorized shares of Class A common stock from 2,250,000,000 to 4,500,000,000. | For | AGAINST — 6 of 7 Equitable funds | For | Approved, 66.7% support |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of amendments to increase the number of authorized shares of preferred stock from 225,000,000 to 450,000,000. | For | AGAINST — 6 of 7 Equitable funds | For | Approved, 66.3% support |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up. | For | AGAINST — 6 of 7 Equitable funds | For | Approved, 66.7% support |
| Cloudflare, Inc. | 2026-06-30 | Approval and adoption of amendments to require the approval of a majority of the independent directors then in office for any acquisition in which we would issue shares of Class C common stock as consideration for such acquisition with a fair market value in excess of $100,000,000. | For | AGAINST — 6 of 7 Equitable funds | For | Approved, 66.8% support |
| Cloudflare, Inc. | 2026-06-30 | Approval, on an advisory basis, of the compensation of our named executive officers. | For | AGAINST — 6 of 7 Equitable funds | For | Approved, 76.2% support |
| Cloudflare, Inc. | 2026-06-30 | 2 wordings Election of Class I directors: Scott Sandell | For | WITHHOLD — 5 of 6 Equitable funds | For | Elected, 90.3% support |
| Aurora Innovation, Inc. | 2026-05-21 | Election of Directors: Gloria Boyland | For | WITHHOLD — 4 of 5 Equitable funds | For | Elected, 97.3% support |
| Arbutus Biopharma Corporation | 2026-05-26 | To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew Gline | For | WITHHOLD — 4 of 5 Equitable funds | Against | Passed (calculated), 86.5% support |
| Semler Scientific, Inc. | 2026-01-13 | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to the named executive officers of Semler Scientific that arises from or otherwise relates to the Merger. | For | AGAINST — 4 of 5 Equitable funds | Against | Approved, 62.3% support |
| BrightSpring Health Services, Inc. | 2026-05-21 | Election of Class II directors: Max Lin | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 76.3% support |
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | 2 wordings Re-election of Class I directors: Julian Baker | For | WITHHOLD — 5 of 8 Equitable funds | For | Elected, 88.6% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Approve the reincorporation of the Company to the State of Texas by conversion. | For | AGAINST — 5 of 8 Equitable funds | For | Approved, 58.4% support |
| FirstCash Holdings, Inc. | 2026-06-09 | Election of Directors: Randel G. Owen | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 87.7% support |
| Etsy, Inc. | 2026-06-09 | Approval of an amendment to our 2024 Equity Incentive Plan to increase the number of shares of our common stock available for issuance. | For | AGAINST — 5 of 8 Equitable funds | For | Approved, 60.2% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Charles Kissner | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 85.5% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Luc Seraphin | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 98.5% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Meera Rao | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 93.9% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Necip Sayiner | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 93.5% support |
| Silicon Laboratories Inc. | 2026-04-23 | To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Navdeep S. Sooch | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 97.6% support |
| Silicon Laboratories Inc. | 2026-04-23 | To elect two Class I directors to serve on the Board of Directors until our 2029 annual meeting of stockholders, or until a successor is duly elected and qualified: Nina Richardson | For | AGAINST — 5 of 8 Equitable funds | For | Passed (calculated), 98.5% support |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr | For | WITHHOLD — 5 of 8 Equitable funds | For | Passed (calculated), 85.9% support |
| Qualys, Inc. | 2026-06-10 | Election of Directors: John A. Zangardi | For | WITHHOLD — 5 of 8 Equitable funds | For | Elected, 94.5% support |
| Qualys, Inc. | 2026-06-10 | Election of Directors: Wendy M. Pfeiffer | For | WITHHOLD — 5 of 8 Equitable funds | For | Elected, 91.4% support |
| Cloudflare, Inc. | 2026-06-30 | Election of Class I directors: Michelle Zatlyn | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 97.0% support |
| Bloom Energy Corporation | 2026-05-21 | Election of our four Class II Directors: Eddy Zervigon | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 76.8% support |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. Chou | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 71.3% support |
| TG Therapeutics, Inc. | 2026-06-11 | Election of Directors: Daniel Hume | For | WITHHOLD — 4 of 6 Equitable funds | For | Passed (calculated), 78.6% support |
| TG Therapeutics, Inc. | 2026-06-11 | Election of Directors: Yann Echelard | For | WITHHOLD — 4 of 6 Equitable funds | For | Passed (calculated), 78.7% support |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D. | For | WITHHOLD — 4 of 6 Equitable funds | For | Passed (calculated), 80.2% support |
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Election of Directors: Michael S. Perry | Against | FOR — 4 of 6 Equitable funds | Against | — |
| Zeta Global Holdings Corp. | 2026-06-16 | Election of Directors: Jeanine Silberblatt | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 90.0% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Election of Directors: Robert Niehaus | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 97.1% support |
| Zeta Global Holdings Corp. | 2026-06-16 | Election of Directors: William Landman | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 93.7% support |
| Axsome Therapeutics, Inc. | 2026-06-05 | Election of Directors: Mark Saad | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 73.6% support |
| Axsome Therapeutics, Inc. | 2026-06-05 | Election of Directors: Susan Mahony, Ph.D., MBA | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 76.7% support |
| Workiva Inc. | 2026-05-28 | Election of Directors: Michael M. Crow, Ph.D. | For | WITHHOLD — 4 of 6 Equitable funds | For | Passed (calculated), 77.9% support |
| Tenable Holdings, Inc. | 2026-05-13 | To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: A. Brooke Seawell | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 74.7% support |
| Tenable Holdings, Inc. | 2026-05-13 | To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Raymond Vicks, Jr. | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 75.9% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Carl Boe Hartman II | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 99.9% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Mark Lynch | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 98.4% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Matthew Calkins | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 98.2% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Robert C. Kramer | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 98.3% support |
| Appian Corporation | 2026-06-03 | Election of Directors: Shirley A. Edwards | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 98.0% support |
| D-Wave Quantum Inc. | 2026-06-04 | Election of two Class I directors to hold office until our 2029 Annual Meeting of Stockholders: Sharon Holt | For | WITHHOLD — 4 of 6 Equitable funds | For | Passed (calculated), 86.1% support |
| Intapp, Inc. | 2025-11-18 | To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Beverly Allen | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 81.0% support |
| Intapp, Inc. | 2025-11-18 | To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Nancy Harris | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 95.2% support |
| Freshworks Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. | For | AGAINST — 4 of 6 Equitable funds | For | Approved, 86.9% support |
| Freshworks Inc. | 2026-05-28 | To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Roxanne S. Austin | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 91.3% support |
| Freshworks Inc. | 2026-05-28 | To elect the four nominees for Class II Directors, each to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Sameer Gandhi | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 93.1% support |
| SPS Commerce, Inc. | 2026-05-28 | Election of Directors: Michael McConnell | For | AGAINST — 4 of 6 Equitable funds | For | Elected, 78.6% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 80.4% support |
| Grindr Inc. | 2026-06-02 | Election of Directors: Daniel Brooks Baer | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 84.8% support |
| Grindr Inc. | 2026-06-02 | Election of Directors: G. Raymond Zage, III | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 88.2% support |
| SoundHound AI, Inc. | 2026-05-22 | Election of Directors: Diana Sroka | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 97.2% support |
| SoundHound AI, Inc. | 2026-05-22 | Election of Directors: Larry Marcus | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 96.2% support |
| Inspire Medical Systems, Inc. | 2026-04-30 | Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. | Against | FOR — 3 of 4 Equitable funds | Against | Approved, 62.0% support |
| C3.ai, Inc. | 2025-10-03 | Election of Class II Directors: General (Ret.) John Hyten | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 97.9% support |
| C3.ai, Inc. | 2025-10-03 | Election of Class II Directors: Richard C. Levin | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 98.0% support |
| Alkami Technology, Inc. | 2026-05-19 | To elect the three nominees for director named herein to serve as Class II directors to hold office until the 2029 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Brian R. Smith | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 72.9% support |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an advisory vote on named executive officer compensation. | Against | FOR — 4 of 6 Equitable funds | Against | — |
| DigitalOcean Holdings, Inc. | 2026-06-15 | Election of Class II Directors: Warren Adelman | For | WITHHOLD — 5 of 9 Equitable funds | For | Passed (calculated), 79.8% support |
| Cytokinetics, Incorporated | 2026-05-27 | 3 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | For | WITHHOLD — 5 of 9 Equitable funds | For | Passed (calculated), 97.0% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Brian F. Hughes | Withhold | FOR — 5 of 9 Equitable funds | Against | Passed (calculated), 97.8% support |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Manchester | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 70.6% support |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa Epperly | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 73.5% support |
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Ian Clark | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 65.0% support |
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Manuel Hidalgo Medina | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 75.5% support |
| Glaukos Corporation | 2026-05-28 | Election of Directors: Aimee S. Weisner | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 95.0% support |
| Glaukos Corporation | 2026-05-28 | Election of Directors: Denice M. Torres | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 78.5% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: David A. Dunbar | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 90.0% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Joseph T. Noonan | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 99.1% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Joseph W. Reitmeier | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 90.1% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Kenneth Napolitano | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 90.3% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Merilee Raines | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 89.9% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Michael J. Dubose | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 86.1% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Rebecca J. Boll | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 90.3% support |
| Watts Water Technologies, Inc. | 2026-05-19 | Election of Directors: Robert J. Pagano, Jr. | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 97.9% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | For | AGAINST — 4 of 7 Equitable funds | For | Passed (calculated), 86.6% support |
| Sanmina Corporation | 2026-03-09 | To elect eight directors of Sanmina Corporation: Mythili Sankaran | For | AGAINST — 4 of 7 Equitable funds | For | Passed (calculated), 56.9% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 85.3% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey | For | WITHHOLD — 4 of 7 Equitable funds | For | Elected, 86.8% support |
| Dycom Industries Inc. | 2026-05-28 | Election of Directors: Peter T. Pruitt, Jr. | For | AGAINST — 4 of 7 Equitable funds | For | Passed (calculated), 96.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Andrea Perez | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Andrew Dudum | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.1% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Anja Manuel | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Christopher Payne | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.4% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: David Wells | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 98.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Deb Autor | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Delos Cosgrove, M.D. | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.9% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Election of Directors: Kare Schultz | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 99.9% support |
| Calix, Inc. | 2026-05-14 | To elect each of the three director nominees named in the proxy statement: Kathleen Crusco | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 90.7% support |
| BioCryst Pharmaceuticals, Inc. | 2026-06-11 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. | For | AGAINST or ABSTAIN — 4 of 7 Equitable funds | For | Approved, 65.4% support |
| Globalstar, Inc. | 2026-05-13 | Approve, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 96.4% support |
| Globalstar, Inc. | 2026-05-13 | Election of Class B Directors: Timothy E. Taylor | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 95.4% support |
| Twist Bioscience Corporation | 2026-02-05 | Election of Class II Directors: Jan Johannessen | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 84.1% support |
| Twist Bioscience Corporation | 2026-02-05 | Election of Class II Directors: Keith Crandell | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 80.5% support |
| Twist Bioscience Corporation | 2026-02-05 | To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 76.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 96.4% support |
| StoneX Group Inc. | 2026-03-10 | Election of Directors: Steven Kass | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 97.2% support |
| Xometry, Inc. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Fabio Rosati | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 90.0% support |
| Xometry, Inc. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Katharine Weymouth | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 86.7% support |
| IES Holdings, Inc. | 2026-02-19 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. | Against | FOR — 3 of 5 Equitable funds | Against | Approved, 92.8% support |
| IES Holdings, Inc. | 2026-02-19 | ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: JOE D. KOSHKIN | Withhold | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 96.6% support |
| IES Holdings, Inc. | 2026-02-19 | ELECTION OF DIRECTORS: TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING AND UNTIL THEIR SUCCESSORS ARE ELECTED AND QUALIFIED: TODD M. CLEVELAND | Withhold | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 97.2% support |
| Braze, Inc. | 2026-06-30 | 2 wordings Election of Two Class II Directors, each to hold office until our 2029 Annual Meeting of Stockholders: Neeraj Agrawal | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 78.6% support |
| StepStone Group Inc. | 2025-09-09 | To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Michael I. McCabe | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 91.4% support |
| StepStone Group Inc. | 2025-09-09 | To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Monte M. Brem | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 85.9% support |
| StepStone Group Inc. | 2025-09-09 | To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Steven R. Mitchell | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 90.8% support |
| BGC Group, Inc. | 2025-11-12 | Approval, on an advisory basis, of executive compensation. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 93.6% support |
| BGC Group, Inc. | 2025-11-12 | Election of Directors: Arthur U. Mbanefo | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 92.5% support |
| BGC Group, Inc. | 2025-11-12 | Election of Directors: David P. Richards | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 94.5% support |
| BGC Group, Inc. | 2025-11-12 | Election of Directors: Linda A. Bell | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 94.2% support |
| BGC Group, Inc. | 2025-11-12 | Election of Directors: William D. Addas | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 94.7% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Mr. David J. Wilson | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 91.6% support |
| Acushnet Holdings Corp. | 2026-06-08 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 82.6% support |
| Remitly Global, Inc. | 2026-06-10 | Election of Directors: Bora Chung | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 96.0% support |
| Remitly Global, Inc. | 2026-06-10 | Election of Directors: Laurent Le Moal | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 96.3% support |
| Remitly Global, Inc. | 2026-06-10 | Election of Directors: Nigel Morris | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 68.9% support |
| Moelis & Company | 2026-06-25 | Election of Directors: Eric Cantor | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 97.8% support |
| Moelis & Company | 2026-06-25 | Election of Directors: Kenneth L. Shropshire | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 87.9% support |
| Moelis & Company | 2026-06-25 | Election of Directors: Kenneth Moelis | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 98.3% support |
| Moelis & Company | 2026-06-25 | Election of Directors: Laila J. Worrell | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 85.0% support |
| Moelis & Company | 2026-06-25 | Election of f Directors: Louise Mirrer | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 84.0% support |
| Moelis & Company | 2026-06-25 | To approve, on an advisory basis, the compensation of our Named Executive Officers. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 76.5% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Aylwin Lewis | Against | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 73.2% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement. | Against | FOR — 3 of 5 Equitable funds | Against | Approved, 51.0% support |
| Construction Partners, Inc. | 2026-03-24 | Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Craig Jennings | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 79.8% support |
| Interparfums, Inc. | 2025-09-10 | To vote for the advisory resolution to approve executive compensation. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 84.3% support |
| CorVel Corporation | 2025-08-07 | To approve the 2025 Stock Incentive Plan. | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 84.0% support |
| CorVel Corporation | 2025-08-07 | To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Jeffrey J. Michael | Withhold | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 84.4% support |
| CorVel Corporation | 2025-08-07 | To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: R. Judd Jessup | Withhold | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 87.6% support |
| Edgewise Therapeutics, Inc. | 2026-06-04 | Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D. | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 70.3% support |
| Franklin Electric Co., Inc. | 2026-05-08 | 2 wordings Elect Victor D. Grizzle and Alok Maskara as directors for terms expiring at the 2029 Annual Meeting of Shareholders: Victor D. Grizzle | For | AGAINST — 3 of 5 Equitable funds | For | — |
| Boot Barn Holdings, Inc. | 2025-08-27 | Election of Directors: Lisa G. Laube | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 78.3% support |
| Acadia Pharmaceuticals Inc. | 2026-05-29 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D. | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 89.4% support |
| Acadia Pharmaceuticals Inc. | 2026-05-29 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 97.7% support |
| Madison Square Garden Entertainment Corp. | 2025-12-10 | Election of the following nominees as directors: Donna M. Coleman | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 79.5% support |
| Madison Square Garden Entertainment Corp. | 2025-12-10 | Election of the following nominees as directors: Frederic V. Salerno | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 79.6% support |
| Madison Square Garden Entertainment Corp. | 2025-12-10 | Election of the following nominees as directors: Martin Bandier | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 79.4% support |
| AvePoint, Inc. | 2026-05-05 | Election of Directors: Brian Michael Brown | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 91.6% support |
| AvePoint, Inc. | 2026-05-05 | Election of Directors: Jeff Epstein | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 76.8% support |
| AvePoint, Inc. | 2026-05-05 | Election of Directors: John Ho | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 94.9% support |
| Cal-Maine Foods, Inc. | 2025-10-03 | Election of Class I Directors: Camille S. Young | For | WITHHOLD — 3 of 5 Equitable funds | For | — |
| Shake Shack Inc. | 2026-06-10 | Election of Directors- Terms expiring at the 2029 Annual Meeting of Stockholders: Tristan Walker | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 74.9% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Andrew Michelmore | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 91.8% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Errol Glasser | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 89.0% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Jarl Berntzen | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 91.4% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Jennifer Bush | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 91.6% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Tamla Olivier | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 91.6% support |
| Century Aluminum Company | 2026-06-15 | Election of Directors: Wilhelm van Jaarsveld | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 99.2% support |
| ADMA Biologics, Inc. | 2026-06-02 | To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. Finger | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 89.0% support |
| ADMA Biologics, Inc. | 2026-06-02 | To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene Salas | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 97.6% support |
| Vertex, Inc. | 2026-06-10 | Election of directors: David DeStefano | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 99.6% support |
| Vertex, Inc. | 2026-06-10 | Election of directors: Eric Andersen | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 97.2% support |
| Upstart Holdings, Inc. | 2026-05-28 | Election of Directors: Ciaran O'Kelly | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 86.9% support |
| Upstart Holdings, Inc. | 2026-05-28 | Election of Directors: Kerry Cooper | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 97.5% support |
| Upstart Holdings, Inc. | 2026-05-28 | Election of Directors: Mary Hentges | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 98.4% support |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 87.0% support |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Election of Directors: Franziska Michor, Ph.D. | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 87.3% support |
| Astrana Health, Inc. | 2026-06-10 | To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: David G. Schmidt | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 93.7% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 71.8% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron Philip | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 68.5% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 70.6% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: David Hodgson | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 60.8% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jacqueline Kosecoff | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 76.1% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jody Bilney | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 76.1% support |
| NovoCure Limited | 2026-06-03 | The approval of our amended and restated 2024 Omnibus Incentive Plan. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 50.3% support |
| UMH Properties, Inc. | 2026-05-27 | Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Angela D. Pruitt-Marriott | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 96.2% support |
| UMH Properties, Inc. | 2026-05-27 | Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Jeffrey A. Carus | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 95.2% support |
| UMH Properties, Inc. | 2026-05-27 | Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Kenneth K. Quigley, Jr. | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 96.0% support |
| UMH Properties, Inc. | 2026-05-27 | Election of four Class II directors, each to serve until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Matthew I. Hirsch | For | WITHHOLD — 3 of 5 Equitable funds | For | Passed (calculated), 59.1% support |
| Quantum Computing Inc. | 2026-06-24 | Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Dr. Carl Weimer | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 82.9% support |
| Quantum Computing Inc. | 2026-06-24 | Elect six directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Robert Fagenson | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 90.6% support |
| Coursera, Inc. | 2026-06-10 | The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Andrew Y. Ng | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 86.1% support |
| Coursera, Inc. | 2026-06-10 | The election of three Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Christopher D. McCarthy | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 84.4% support |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Amendment to our Second Amended and Restated 2020 Incentive Plan. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 74.8% support |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Election of Directors: Claude Demby | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 76.7% support |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Non-binding advisory vote to approve our named executive officer compensation. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 75.3% support |
| eXp World Holdings, Inc. | 2026-05-08 | Election of Directors to serve for a one-year term expiring in 2027. Randall Miles | Against | FOR — 3 of 5 Equitable funds | Against | Passed (calculated), 88.9% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To hold an advisory vote to approve named executive officer compensation. | For | AGAINST — 3 of 5 Equitable funds | For | — |
| Jamf Holding Corp. | 2026-01-08 | A proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), dated as of October 28, 2025, by and among Jamf, Jawbreaker Parent, Inc., a Delaware corporation ("Parent"), and Jawbreaker Merger Sub, Inc., a D | For | ABSTAIN — 3 of 5 Equitable funds | For | Approved, 99.8% support |
| LiveRamp Holdings, Inc. | 2025-08-12 | Election of Directors: Brian O'Kelley | For | AGAINST — 3 of 5 Equitable funds | For | Elected, 95.6% support |
| LiveRamp Holdings, Inc. | 2025-08-12 | Election of Directors: Clark M. Kokich | For | AGAINST — 3 of 5 Equitable funds | For | Elected, 92.3% support |
| Moog Inc. | 2026-02-10 | Election of directors: Class A Director - Term Expiring 2029: Brenda Reichelderfer | For | WITHHOLD — 3 of 5 Equitable funds | For | Elected, 95.0% support |
| StoneCo Ltd. | 2026-04-23 | Accept Financial Statements and Statutory Reports | Abstain | FOR — 3 of 5 Equitable funds | Against | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Antonio Silveira | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Diego Fresco Gutierrez | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Gilberto Caldart | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Jose Alexandre Scheinkman | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Luciana Ibiapina Lira Aguiar | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Luis Henrique Cals de Beauclair Guimaraes | For | AGAINST — 3 of 5 Equitable funds | For | — |
| StoneCo Ltd. | 2026-04-23 | Elect Director Mauricio Luis Luchetti | For | AGAINST — 3 of 5 Equitable funds | For | — |
Download all 208 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 89.7% of this fund’s 8,596 such votes could be given a sector; the other 882 (10.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 1,905 | 16 | 0.8% |
| Consumer Discretionary | 1,404 | 8 | 0.6% |
| Finance | 1,204 | 2 | 0.2% |
| Technology | 1,095 | 5 | 0.5% |
| Industrials | 920 | 3 | 0.3% |
| Energy | 260 | 0 | 0.0% |
| Real Estate | 234 | 0 | 0.0% |
| Miscellaneous | 169 | 0 | 0.0% |
| Utilities | 169 | 0 | 0.0% |
| Basic Materials | 123 | 0 | 0.0% |
| Consumer Staples | 118 | 3 | 2.5% |
| Telecommunications | 113 | 1 | 0.9% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,699 | 16 |
| Audit-related | 1,065 | 0 |
| Say-on-Pay | 1,037 | 4 |
| Compensation | 371 | 1 |
| Corporate Governance | 263 | 9 |
| Capital Structure | 151 | 4 |
| Extraordinary Transactions | 100 | 0 |
| Shareholder Rights and Defenses | 24 | 1 |
| Other | 10 | 0 |
| Diversity, Equity, and Inclusion | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| agilon health, inc. | March 17, 2026 | $383M | 2 | 0 |
| Cloudflare, Inc. | June 30, 2026 | $24M | 14 | 0 |
| agilon health, inc. | June 2, 2026 | $15M | 5 | 1 |
| HealthEquity, Inc. | June 25, 2026 | $12M | 14 | 0 |
| GRAIL, Inc. | June 18, 2026 | $12M | 3 | 0 |
| Appian Corporation | June 3, 2026 | $11M | 12 | 2 |
| Bloom Energy Corporation | May 21, 2026 | $5M | 8 | 0 |
| Etsy, Inc. | June 9, 2026 | $5M | 7 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 2, 2026 | agilon health, inc. | Election of Class II Directors: Ronald Williams | For | Against |
| June 3, 2026 | Appian Corporation | Election of Directors: Barbara Bobbie Kilberg | For | Against |
| June 3, 2026 | Appian Corporation | To approve the Appian Corporation Amended and Restated 2017 Equity Incentive Plan. | For | Against |
| June 9, 2026 | Etsy, Inc. | Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposal | Against | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
| May 7, 2026 | Wolverine World Wide, Inc. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | Against | For |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft Shareholder proposal | Withhold | For |
Meetings with a proxy contest or competing nominees (8 in 2025-2026), and how the fund voted the items on its ballot.
8,726 ballot items at 1,177 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, EQ/Morgan Stanley Small Cap Growth Portfolio voted at 1,177 shareholder meetings of 1,109 companies, on 8,726 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 39 times. Its most frequent area of disagreement was director elections (16 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (94.5% against 92.5%). It voted differently from most Equitable funds on 208 items. 8 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.